Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CRVO
CRVO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CRVO News
CervoMed Showcases Neflamapimod's Impact on DLB at AAIC
2d ago
Newsfilter
CervoMed Inc. Prices 2.5 Million Shares at $4.00 Each
Jun 22 2026
NASDAQ.COM
CervoMed Secures New Patent and Raises $10 Million
Jun 18 2026
stocktwits
CervoMed Completes Direct Offering of 2.5 Million Shares
Jun 18 2026
Newsfilter
CervoMed and Others See Significant Stock Gains
Jun 17 2026
NASDAQ.COM
Emerging Companies in Biotech and AI Gain Attention
Jun 16 2026
Newsfilter
SpaceX to Acquire Anysphere in Strategic Move
Jun 16 2026
Yahoo Finance
Biotech Companies Achieve Significant Milestones
Jun 16 2026
Newsfilter
Biotech Stocks Show Significant Pre-Market Activity
Jun 16 2026
NASDAQ.COM
CervoMed to Participate in Investor Meetings at Neuro Perspectives Summit
Jun 12 2026
Newsfilter
CervoMed Financing Plan Triggers Stock Price Plunge
Jun 10 2026
stocktwits
CervoMed Secures $10.5 Million Financing to Advance Neflamapimod
Jun 10 2026
Newsfilter
CervoMed Reports Q1 Financial Results with Increased Losses
May 18 2026
seekingalpha
CervoMed Advances Phase 3 Trial for DLB
May 18 2026
Newsfilter
CervoMed Presents New Therapy for Neurodegenerative Disease
Apr 22 2026
Newsfilter
CervoMed Updates on Clinical Trial Progress for Neflamapimod
Apr 07 2026
Newsfilter
Show More News
